Auroras Cannabis President said this:
“We see an important market for cannabis-based products that are more narrowly targeted at specific therapeutic areas but that are higher value add and being involved with initiatives such as PreveCeutical’s is part of our strategy to gain access to these types of products,” said Terry Booth, CEO of Aurora.

NEWS LINK HERE:
https://www.proactiveinvestors.co.uk/companies/news/206403/preveceutical-medical-poised-to-buy-penta-5-group-in-share-deal-206403.html